Skip to main content
. 2021 Nov 21;9(4):2104264. doi: 10.1002/advs.202104264

Figure 4.

Figure 4

In vitro and in vivo antiplatelet activities. A) The expression levels of sCD40L in the activated platelets after treatments, in which thrombin was utilized to activate the platelets (n = 3). B) A schematic diagram of tail bleeding assay. C,D) The bleeding time and volume in the tail bleeding assay (n = 5), *p < 0.05, **p < 0.01, ***p < 0.001, ns: no significance.